HRT Financial
MENS icon

HRT Financial’s Jyong Biotech MENS Stock Holding History

HRT Financial’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-50,423
Closed -$104K – 6280
2026
Q2 		$104K Buy
50,423
+38,656
+329% +$82K ﹤0.01% 3605
2026
Q1 		$25K Buy
+11,767
New +$28.8K ﹤0.01% 3547
2025
Q4 		– Sell
-20,819
Closed -$819K – 4330
2025
Q3 		$819K Sell
20,819
-2,103
-9% -$75.7K ﹤0.01% 1627
2025
Q2 		$190K Buy
+22,922
New +$197K ﹤0.01% 2091

Other funds holding MENS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

HRT Financial's MENS Position: Q3 2026 in Review

HRT Financial sold out of Jyong Biotech (MENS) in Q3 2026, closing a stake of 50,423 shares — an estimated $104K sold.

HRT Financial first reported a position in MENS in Q2 2025 and held it in 4 quarters. The position peaked at $819K in Q3 2025. 14 funds tracked by Wall St. Rank hold MENS as of Q3 2026.

  • HRT Financial reported no remaining Jyong Biotech position as of Q3 2026 after selling out during the quarter.
  • HRT Financial sold 50,423 Jyong Biotech shares in Q3 2026, an estimated $104K.
  • HRT Financial first reported a position in Jyong Biotech in Q2 2025 and held it in 4 quarters.
  • HRT Financial's Jyong Biotech position peaked at $819K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Jyong Biotech as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.